The comparison of single dose preemptive intravenous ketorolac and paracetamol on postoperative pain after septorhinoplasty

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180922041084N6

Enrollment

108

Registered

2022-03-08

Start date

2022-04-09

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rhinoplasty surgery.

Interventions

Intervention 1: Intervention group: To the group receiving ketorolac (36 people) 40 mg of ketorolac (made by Raha company) is injected intravenously in 100cc of normal saline 30 minutes before the ope

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Obtaining informed consent Candidate patients for rhinoplasty with age group of 18-50 years and class (ASA) I, II

Exclusion criteria

Exclusion criteria: History of drug allergy to ketorolac and paracetamol History of long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) and narcotics History of gastrointestinal bleeding, Stomach ulcers or inflammatory bowel disease Diabetes or neuropathic diseases

Design outcomes

Primary

Measure	Time frame
Post operative pain. Timepoint: At 1, 6, 12 and 24 hours after surgery. Method of measurement: VAS SCORE scoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShirin Farrokhyani

Shiraz University of Medical Sciences

poopanak@gmail.com+98 71 3630 4312

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026